Genomes and Genes
substance induced psychoses
Summary: Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
Publications188 found, 100 shown here
- [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis]Roland Härtel-Petri
Abteilung Klinische Suchtmedizin, Klinik fur Psychiatrie und Psychotherapie, Bezirkskrankenhaus Bayreuth
Psychiatr Prax 32:13-7. 2005..In some regions methamphetamin is particularly common. Flashbacks, which can be triggered by psychosocial stress, as well as the age of the usually young patients lead to the differential diagnosis of schizophrenia...
- Psychological effects of ketamine in healthy volunteers. Phenomenological studyE Pomarol-Clotet
Benito Menni CASM, Barcelona, Spain
Br J Psychiatry 189:173-9. 2006..The psychosis-inducing effect of ketamine is important evidence supporting the glutamate hypothesis of schizophrenia. However, the symptoms the drug produces have not been described systematically...
- The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosisDEEPAK CYRIL D'SOUZA
Schizophrenia Biological Research Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Neuropsychopharmacology 29:1558-72. 2004..These data warrant further study of whether brain cannabinoid receptor function contributes to the pathophysiology of psychotic disorders...
- Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosisHiroshi Ujike
Department of Neuropsychiatry, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
Ann N Y Acad Sci 1025:279-87. 2004..Molecular findings using animal sensitization models may facilitate a better understanding of, and open the way for innovative therapies for, METH psychosis and also chronic schizophrenia...
- Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humansF X Vollenweider
Psychiatric University Hospital Zurich, Research Department, Switzerland
J Psychiatr Res 34:35-43. 2000..These results provide evidence that the glutamatergic NMDA receptor may contribute to psychotic symptom formation via modulation of the DA system...
- Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approachA Breier
Experimental Therapeutics Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA
Synapse 29:142-7. 1998..The implications of this brain imaging method for studies of schizophrenia and the mechanism of action of antipsychotic drugs are discussed...
- Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)F X Vollenweider
Research Department, Psychiatric University Hospital of Zurich, Switzerland
Eur Neuropsychopharmacol 7:9-24. 1997....
- Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET studyJames M Stone
Institute of Psychiatry, King s College London, London, UK
Psychopharmacology (Berl) 197:401-8. 2008..Ketamine induces effects resembling both positive and negative psychotic symptoms of schizophrenia. These are thought to arise through its action as an uncompetitive antagonist of the N-methyl-D-aspartate (NMDA) receptor...
- Psychopathological consequences of ketamineJ M Stone
Br J Psychiatry 189:565-6. 2006
- Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosisEuphrosyne Gouzoulis-Mayfrank
Department of Psychiatry and Psychotherapy, University of Cologne, Germany
Neuropsychopharmacology 31:431-41. 2006..Blunted IOR may underlie or predispose to different psychotic manifestations, but particularly to those with prominent positive symptoms...
- Serotonin research: contributions to understanding psychosesMark A Geyer
Department of Psychiatry, University of California San Diego, Room B 418 Clinical Teaching Facility, 212 W Dickinson Street, San Diego, CA 92103, USA
Trends Pharmacol Sci 29:445-53. 2008..This review summarizes experimental assessments of the serotonergic hallucinogen model psychosis in relation to the serotonin hypothesis of schizophrenia...
- Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosisPhilip R Corlett
Brain Mapping Unit, Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, England
Arch Gen Psychiatry 63:611-21. 2006..Establishing a neurobiological account of delusion formation that links cognitive processes, brain activity, and symptoms is important to furthering our understanding of psychosis...
- Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousnessDagmar Koethe
Department of Psychiatry and Psychotherapy, University of Cologne, 50924 Cologne, Germany
Schizophr Res 88:142-50. 2006....
- [Reefer madness revisited: cannabis and psychosis]John Witton
Rev Bras Psiquiatr 26:2-3. 2004
- Curses, madness, and mefloquineOladipo Kukoyi
Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
Psychosomatics 44:339-41. 2003
- Psychotic symptoms in methamphetamine psychotic in-patientsManit Srisurapanont
Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
Int J Neuropsychopharmacol 6:347-52. 2003..The clinical findings do not support the shortcomings of amphetamine-induced psychosis in modelling the negative symptoms of schizophrenia...
- Intoxication and settled insanity: a finding of not guilty by reason of insanityJeff Feix
Central State Hospital, Forensic Unit, 26317 Washington Street, Petersburg, VA 23803, USA
J Am Acad Psychiatry Law 35:172-82. 2007..The evaluating clinician must still determine, even when a threshold condition is considered to be present, whether statutory criteria for the insanity defense (for the jurisdiction in which the crime allegedly took place) are met...
- Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movementsTomoko Mikami
Section of Psychiatry and Behavioral Science, Graduate School of Tokyo Medical and Dental University, Tokyo, Japan
Psychiatry Clin Neurosci 57:433-40. 2003..It did not differ from that of the schizophrenic subjects. These results suggest that the severely disturbed group of patients with the persistent type of MAP psychosis have a vulnerability to schizophrenia...
- Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosisBjørn Rishovd Rund
Department of Psychiatry, Ulleval University Hospital, Oslo, Norway
Am J Psychiatry 161:466-72. 2004....
- Cannabis and brain morphology in recent-onset schizophreniaW Cahn
Schizophr Res 67:305-7. 2004
- Quetiapine improves psychotic symptoms and cognition in Parkinson's diseaseJorge L Juncos
Neurology Department, Emory University, Atlanta, Georgia 30329, USA
Mov Disord 19:29-35. 2004....
- Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepamNobutomo Yamamoto
Department of Psychiatry, Shimofusa Psychiatric Medical Center, Chiba City, Chiba, Japan
Psychiatry Clin Neurosci 61:691-4. 2007..Tardive dystonia is currently treated on a trial-and-error basis. Accumulation of further cases similar to the present one is very important for establishing an effective treatment...
- Dependence and chronic psychosis with D-nor-pseudoephedrineB Alevizos
Department of Psychiatry, University of Athens, Eginition Hospital, 74 Vass Sophias Avenue, Athens 11528, Greece
Eur Psychiatry 18:423-5. 2003
- Potential for antipsychotic and psychotomimetic effects of A2A receptor modulationScott M Weiss
Vernalis Research Ltd, Wokingham, UK
Neurology 61:S88-93. 2003..Preclinical studies using selective A2A receptor antagonists suggest that this class of compound has a low propensity to elicit psychotomimetic side effects or exacerbate those induced by D2 receptor agonists...
- Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorderSarah E Flanders
Department of Psychiatry, James Fletcher Hospital, Newcastle, NSW, Australia
Aust N Z J Psychiatry 41:934-6. 2007..To describe and discuss the implications for treatment of 3 cases of dually diagnosed patients with a primary psychotic disorder who have developed persisting, cannabis-oriented delusional systems...
- [Depression and schizophrenia]A V Smulevich
Zh Nevrol Psikhiatr Im S S Korsakova 103:4-13. 2003..Its induced by antipsychotics and combine with extrapyramidal disorders...
- Psychosis in Parkinson's diseaseWerner Poewe
Department of Neurology, University of Innsbruck, Innsbruck, Austria
Mov Disord 18:S80-7. 2003..Cholinesterase inhibitors may prove an additional option in psychotic PD patients with dementia...
- Kynurenic acid and schizophreniaSophie Erhardt
Dept of Physiology and Pharmacology, Karolinska Institutet, SE 171 77 Stockholm, Sweden
Adv Exp Med Biol 527:155-65. 2003..The present study suggests a contribution of KYNA in the pathogenesis of schizophrenia and link the dopamine hypothesis of schizophrenia together with the idea of a deficiency of glutamate function in this disease...
- Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychoticsJean Pierre Lindenmayer
Manhattan Psychiatric Center, New York University School of Medicine, New York, NY 10035, USA
J Clin Psychiatry 65:1084-9. 2004..The safety and efficacy of the first long-acting injectable atypical antipsychotic, risperidone, were assessed in stable patients with schizophrenia switched from oral antipsychotic medications...
- A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosisThawatchai Leelahanaj
Department of Psychiatry and Neurology, Phramongkutklao Hospital, Bangkok, Thiland
J Med Assoc Thai 88:S43-52. 2005..To compare the efficacy and tolerability of olanzapines and haloperidol in treating patients with amphetamine psychosis...
- Long-term follow-up (24 months) of quetiapine treatment in drug-induced Parkinson disease psychosisColin Klein
Department of Neurology, Assaf Harofeh Medical Center, Zerifin, Sackler School of Medicine, Tel Aviv University, Israel
Clin Neuropharmacol 29:215-9. 2006..To evaluate the long-term outcome of quetiapine (QTP) use for drug-induced psychosis in Parkinson disease as assessed by the primary caregiver using the Clinical Global Impression Scale...
- Drug-induced psychosis associated with crystalline methamphetamineGlenys Dore
Macquarie Hospital, Sydney, NSW, Australia
Australas Psychiatry 14:86-9. 2006..A case of drug-induced psychosis related to crystalline methamphetamine is described, highlighting the phenomenology and relevant treatment...
- Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazoleMichele Raja
Servizio Psichiatrico di Diagnosi e Cura, Ospedale Santo Spirito, Rome, Italy
Int J Neuropsychopharmacol 10:107-10. 2007..Conversely, the effectiveness on negative symptoms seem consistent both in patients with or without antipsychotic response. A low dose may be indicated at the beginning of treatment to assess the kind of response...
- HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetamine-dependent men who have sex with menJames A Peck
Friends Research Institute, Los Angeles, CA, USA
J Addict Dis 24:115-32. 2005....
- ["Usual" cannabis abuse producing an unusual incident]H J Heppner
Klinikum Nurnberg Nord, Medizinische Klinik 2, Intensivmedizin Toxikologie, Lehrstuhl Innere Medizin V Geriatrie, FAU Erlangen Nürnberg
Dtsch Med Wochenschr 132:560-2. 2007..Except for regular abuse of cannabis there was no medical history of note. He had a sinus tachycardia (130 bpm), a slow pupillary reflex, bilateral hyposphagma and subcutaneous emphysema around the neck and shoulders...
- [Schizoid psychosis during cannabis intake (case report)]Peter Gaszner
Orszagos Pszichiatriai es Neurologiai Intezet, Klinikai Pszichofarmakológiai, Osztálya
Neuropsychopharmacol Hung 6:90-2. 2004..Marihuana is working on the dopamine system and may cause schizoid psychosis, sometimes permanent psychosis. Cannabis, this light drug might not be a "safe" agent...
- Hospital separations for cannabis- and methamphetamine-related psychotic episodes in AustraliaLouisa Degenhardt
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
Med J Aust 186:342-5. 2007..To examine trends in hospital separations related to "drug-induced" psychosis for cannabis and methamphetamine, in the context of patterns of cannabis and methamphetamine use in the Australian population...
- A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosisJ Boydell
Division of Psychological Medicine, PO Box 63, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London, SE5 8AF, United Kingdom
Schizophr Res 93:203-10. 2007....
- Clinical profiles, scope and general findings of the Western Sydney First Episode Psychosis ProjectAnthony Harris
University of Sydney, Westmead Hospital, New South Wales, Australia
Aust N Z J Psychiatry 39:36-43. 2005..To examine the clinical profile, treatment and social functioning of a community-based sample of young people presenting with their first episode of psychosis...
- Risperidone-induced rabbit syndrome in mood disorderIbrahim Eren
Department of Psychiatry, Suleyman Demirel University, Cunur, Isparta 32260, Turkey
Eur Psychiatry 19:452-3. 2004
- Clozapine and typical antipsychoticsDavid E Ross
Am J Psychiatry 161:1925-6. 2004
- Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?Charles H Large
Psychiatry CEDD, GlaxoSmithKline, Via Fleming 4, 37135 Verona, Italy
J Psychopharmacol 21:283-301. 2007....
- Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughingJan Schindehütte
Paracelsus Elena Klinik Kassel, Klinikstrasse 16, 34128 Kassel, Germany
Clin Neurol Neurosurg 109:188-91. 2007..Two patients developed pathological laughing as a possible side-effect of ziprasidone. Ziprasidone may serve as an additional "atypical anti-psychotic" for the treatment of DP in PD but can also induce deterioration of motor function...
- Advanced pediatric psychopharmacologyJose Vito
Division of Child and Adolescent Psychiatry, State University of New York, Brooklyn, New York, USA
J Child Adolesc Psychopharmacol 16:498-502. 2006
- Modelling prefrontal cortex deficits in schizophrenia: implications for treatmentJ A Pratt
PsyRING Psychiatric Research Institute of Neuroscience in Glasgow, West Medical Building, University of Glasgow, Glasgow, UK
Br J Pharmacol 153:S465-70. 2008..As such it is likely to be a valuable translational model for understanding the neurobiological mechanisms underlying hypofrontality and for identifying and validating novel drug targets that may restore PFC deficits in schizophrenia...
- [Minocycline as a therapeutic drug for methamphetamine use disorders]Kenji Hashimoto
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1 8 1 Inohana, Chiba, 260 8670 Japan
Nihon Shinkei Seishin Yakurigaku Zasshi 28:19-22. 2008..In this review, we discuss minocycline as a new potential therapeutic drug for schizophrenia as well as psychosis associated with these abused drugs...
- [Basic and clinical studies on methampetamine-related psychosis]Mitsumoto Sato
Seishin Shinkeigaku Zasshi 104:179-90. 2002
- Risk factors for treatment-resistive methamphetamine psychosisDaryl Fujii
J Neuropsychiatry Clin Neurosci 14:239-40. 2002
- Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorderHoward C Margolese
Clinical Psychopharmacology Unit, Allan Memorial Institute, McGill University Health Centre, Montreal, Quebec, Canada
J Clin Psychopharmacol 22:347-52. 2002..Seeman and Tallerico3 have proposed pharmacologic explanations for quetiapine and clozapine drug-induced rebound phenomena...
- Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric studySrihari S Bangalore
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213 USA
Schizophr Res 99:1-6. 2008..The results suggest that cannabis use may be associated with altered brain structure, in particular regions rich in CB1 receptors. These findings need to be confirmed by larger, prospective studies...
- Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophreniaMikkel Arendt
Centre for Psychiatric Research, Aarhus University Hospital, Skovagervej 2, Risskov, 8240 Risskov, Denmark
Arch Gen Psychiatry 65:1269-74. 2008..Cannabis-induced psychosis is considered a distinct clinical entity in the existing psychiatric diagnostic systems. However, the validity of the diagnosis is uncertain...
- [Ziprasidone in Parkinsonian dopamine psychosis]E Duran-Ferreras
Servicio de Neurologia, Hospital Universitario Virgen Macarena, 41003 Sevilla, Espana
Rev Neurol 46:476-80. 2008..In this work, we examine the role that ziprasidone (ZPS) can play in PDP...
- Use of quetiapine in elderly patientsPierre N Tariot
Department of Psychiatry, University of Rochester School of Medicine, Monroe Community Hospital, Rochester, NY 14620, USA
J Clin Psychiatry 63:21-6. 2002....
- Cannabis and psychiatric disorders: it is not only addictionF Markus Leweke
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany
Addict Biol 13:264-75. 2008..With numerous open questions and controversial results, further research is required to specify and extend the findings in this area, which provides a promising target for novel pharmacotherapeutic interventions...
- [Levodopa dependency in Parkinson's disease: case report and review]U Muller
Klinik und Poliklinik fur Psychiatrie, Universitat Leipzig, Germany
Nervenarzt 73:887-91. 2002....
- Cabergoline-induced psychotic exacerbation in schizophrenic patientsShen Chieh Chang
Department of Psychiatry, Taipei Medical University Wan Fang Medical Center, Taipei, Taiwan
Gen Hosp Psychiatry 30:378-80. 2008..Hyperprolactinemia is a well-recognized side effect of antipsychotic treatment. Cabergoline, a dopamine agonist, has been introduced on the market to treat hyperprolactinemia, even secondary to antipsychotic use...
- Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of researchJ B Kirkbride
Department of Psychiatry, University of Cambridge, Addenbrooke s Hospital, Cambridge CB2 2QQ, UK
Int J Epidemiol 38:1255-64. 2009..We had the opportunity to determine whether incidence had changed over a 20-year period in a single setting, and test whether this could be explained by demographic or clinical changes...
- Sources of diagnostic uncertainty for chronically psychotic cocaine abusersA Shaner
West Los Angeles Veterans Affairs Medical Center, CA, USA
Psychiatr Serv 49:684-90. 1998..This study determined the sources and frequency of diagnostic uncertainty for patients with chronic psychosis and active cocaine abuse or dependence and assessed the usefulness of prospective follow-up in clarifying diagnosis...
- Management of psychotic aspects of Parkinson's diseaseJ L Juncos
Emory University School of Medicine Movement Disorders Program and the Wesley Woods Center of Aging, Atlanta, GA 30329, USA
J Clin Psychiatry 60:42-53. 1999....
- Comments on the paper 'The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study'Jennifer M Loftis
Hum Psychopharmacol 20:211-2; author reply 213. 2005
- Cannabis use and psychotic disorders: an updateWayne Hall
Office of Public Policy and Ethics, Institute for Molecular Bioscience University of Queensland Australia
Drug Alcohol Rev 23:433-43. 2004..It seems more likely that cannabis use can precipitate schizophrenia in vulnerable individuals. There is also reasonable evidence for the third hypothesis that cannabis use exacerbates psychosis...
- Polar hysteria: an expression of hypervitaminosis AJames O'Donnell
Department of Pharmacology, Rush University Medical Center, Chicago, Illinois, USA
Am J Ther 11:507-16. 2004....
- [An auto-iatrogenic disease]W H Reinhart
Medizinische Klinik, Kantonsspital, Chur
Ther Umsch 61:715-9. 2004..This case illustrates the dangers of self-treatment by doctors and the difficulties in treating a physician...
- Development of subtle psychotic symptoms with memantine: a case reportEdward D Huey
J Clin Psychiatry 66:658-9. 2005
- Drug induced autoenucleation with resultant chiasmal damageRichard K Imes
Br J Ophthalmol 89:783. 2005
- Combined intoxication with methylone and 5-MeO-MIPTEiji Shimizu
Department of Integrative Neurophysiology, Graduate School of Medicine, Chiba University, 1 8 1 Inohana, Chuouku, Chiba 260 8670, Japan
Prog Neuropsychopharmacol Biol Psychiatry 31:288-91. 2007..This case report suggests that clinicians should be alert to the possibility of the emergence of methylone or 5-MeO-MIPT intoxication, and substance-related mental disorder may be complicated by combined use of other psychoactive drugs...
- Recovery of neuropsychological functions during reduction in use of phencyclidineJ Cosgrove
California School of Professional Psychology, Fresno 93721
J Clin Psychol 47:159-69. 1991..Analysis of each variable revealed that substantial improvement occurred on the acquisition, recall, and delayed recall scores of the Randt Memory Test. Improvement also was noted for some individuals on Trails B and Digit Symbol tests...
- Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesiaU Andersson
Psychiatric Research Center, University of Uppsala, Sweden
Psychopharmacology (Berl) 94:167-71. 1988..It is concluded that remoxipride in the dose range used has anti-dyskinetic effects but does not induce parkinsonism...
- Psychotic patients who become worse on neurolepticsM B Bowers
Yale University School of Medicine, Department of Psychiatry, New Haven, Connecticut 06519
J Clin Psychopharmacol 8:417-21. 1988..We propose that some patients with affective psychoses are uniquely susceptible to profound blockade of the nigrostriatal dopaminergic system by neuroleptics...
- Admission of Parkinsonian patients to a neurological ward in a community hospitalColin Klein
Department of Neurology, Assaf Harofeh Medical Center, Zerifin, Sackler Faculty Medicine, Tel Aviv University, Tel Aviv, Israel
J Neural Transm 116:1509-12. 2009..After analyzing our results, we instituted an "open door" policy, where patients are free to come to the Parkinson's clinic without appointment. This policy should improve control of PD symptoms and diminish hospitalizations...
- Adverse reaction to mefloquine associated with ethanol ingestionR C Wittes
Division of Infectious Disease, Ottawa Civic Hospital, Ont
CMAJ 152:515-7. 1995..It is hypothesized that the combination of MFQ and ethanol caused the two episodes of severe psychiatric disturbance...
- Combating psychosis in Parkinson's disease patients: the use of antipsychotic drugsKelvin L Chou
Department of Clinical Neurosciences, Brown Medical School, Providence, Rhode Island, USA
Expert Opin Investig Drugs 15:339-49. 2006....
- Use of khat and posttraumatic stress disorder as risk factors for psychotic symptoms: a study of Somali combatantsMichael Odenwald
University of Konstanz, Konstanz, Germany
Soc Sci Med 69:1040-8. 2009..However, the proposed causal chain needs to be confirmed in longitudinal studies. Demobilization and reintegration programs in Somalia need to be prepared to deal with complex psychological problems...
- [Rethinking criminal responsibility: practical application of operational diagnosis and gnostic into expert testimony]Takayuki Okada
National Center of Neurology and Psychiatry, Institute of Mental Health, Department of Forensic Psychiatry
Seishin Shinkeigaku Zasshi 107:920-35. 2005..The authors also discussed various topics related to criminal responsibility including Asperger's syndrome, illicit drug intoxication, and prescribed drug intoxication...
- [Significance of historical and current hallucinogenic research in psychiatry]L Hermle
Fachkrankenhaus für Psychiatrie und Neurologie, Christophsbad, Goppingen
Nervenarzt 64:562-71. 1993..It is argued that from a systematic as well as from a methodological viewpoint the traditional approach of experimental psychosis represents a valuable tool in psychiatric research...
- [Neurotoxicity secondary to ifosfamide manifesting as psychosis and comma]J A Valdueza Beneitez
Farm Hosp 30:315-6. 2006
- The endocannabinoid system as a target for modelling psychosisDagmar Koethe
Central Institute of Mental Health, Ruprecht Karls University Heidelberg, Mannheim, Germany
Psychopharmacology (Berl) 206:551-61. 2009..These "altered states of consciousness" provide a long-standing and valid approach to enhance our understanding of certain aspects of schizophrenia...
- Khat chewing: an emerging drug concern in Australia?Johana Stefan
Aust N Z J Psychiatry 39:842-3. 2005
- Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosisHiroshi Ujike
Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Prog Neuropsychopharmacol Biol Psychiatry 33:625-9. 2009..00037, OR=3.62, 95% CI 2.48-5.28). These findings revealed that genetic variants of DRD2, but not DRD3 or DRD4, confer individual risks for rapid onset, prolonged duration, and spontaneous relapse of methamphetamine psychosis...
- A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosisM Harano
Department of Neuropsychiatry, Kurume University School of Medicine, Kurume, Fukuoka, Japan
Ann N Y Acad Sci 1025:307-15. 2004..It is suggested that in methamphetamine psychosis the TaqI A polymorphism not only regulates prolongation of psychosis symptoms but also influences the form of the temporal lobe...
- GABA-ergic neurons and the neurobiology of schizophrenia and other psychosesE B Keverne
Sub Department of Animal Behaviour, University of Cambridge, UK
Brain Res Bull 48:467-73. 1999..These interneurons have highly divergent inhibitory projections to large numbers of pyramidal neurons and are themselves synchronised by the ascending dopamine and serotonin innervations...
- [Experimental animal models of psychoses]V Dauge
Encephale 29:S12-5. 2003
- Acute psychosis associated with levetiracetamSotiris Youroukos
First Department of Paediatrics, Athens University Medical School, St Sophia Children s Hospital, Athens, Greece
Epileptic Disord 5:117-9. 2003..The psychotic behavior resolved completely soon after the discontinuation of levetiracetam...
- Visual scan paths in first-episode schizophrenia and cannabis-induced psychosisPhilip J Benson
College of Life Sciences and Medicine, King s College, University of Aberdeen, UK
J Psychiatry Neurosci 32:267-74. 2007..We used higher-order statistical methods to examine spatiotemporal characteristics of scan paths to determine whether viewing behaviour was distinguishable on a continuum...
- Case report: an ingestion of Hawaiian Baby Woodrose seeds associated with acute psychosisJeffrey H Gertsch
University of Hawaii, John A Burns School of Medicine, Department of Psychiatry, University Tower, 4th Floor, 1356 Lusitana Street, Honolulu, Hawaii 96813, USA
Hawaii Med J 62:127, 129. 2003....
- [Probable levetiracetam-induced psychosis]Joan Roig
Med Clin (Barc) 129:278. 2007
- Ketamine associated psychedelic effects and dependenceD K Lim
Department of Adult Psychiatry Unit 3, Woodbridge Hospital, Singapore 539747
Singapore Med J 44:31-4. 2003..The detection of ketamine abuse requires a high index of suspicion and needs to be considered when there is an acute presentation with multi-modal hallucinations and psychosis...
- The importance of being seizure free: topiramate and psychopathology in epilepsyMarco Mula
Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
Epilepsy Behav 4:430-4. 2003..We observed that psychopathology was related to seizure control in a subgroup of patients. The role of forced normalization, interlinked with interactions with other antiepileptic drugs, could be relevant...
- Analysis of association of clinical correlates and 5-HTTLPR polymorphism with suicidal behavior among Chinese methamphetamine abusersChih Ken Chen
Department of Psychiatry, Chang Gung Memorial Hospital, Keelung, Taiwan
Psychiatry Clin Neurosci 61:479-86. 2007....
- Corticosteroids, immune suppression, and psychosisDana C Perantie
Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9070, USA
Curr Psychiatry Rep 4:171-6. 2002..However, the role of the immune system in mediating the psychiatric disturbances with each of these conditions is not clear. Directions for further research and treatment considerations are discussed...
- Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's diseaseK Yamada
Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
Acta Neurochir (Wien) 150:15-22; discussion 22. 2008..We retrospectively investigated the effects of bilateral STN stimulation on the axial signs unresponsive to levodopa in Japanese patients with PD...
- The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementiaSujana Reddy
Department of Psychiatry, Albany Medical Center, Albany, New York 12205, USA
Mov Disord 17:676-81. 2002..We conclude that quetiapine is effective in improving psychosis in approximately 80% of PD patients both with and without dementia. Patients with dementia seem to have a higher propensity for worsening of motor symptoms...
- Six months follow-up of patients with methamphetamine psychosisH S Yeh
Department of Psychiatry, Taipei Veterans General Hospital, 201, Sec 2, Shih Pai Road, Taipei 112, Taiwan
Zhonghua Yi Xue Za Zhi (Taipei) 64:388-94. 2001..Some authors preferred MAP psychosis model of schizophrenia, while other studies found difference between the two groups of patients in the aspects of negative symptoms...
- Atypical antipsychotics: mechanism of actionPhilip Seeman
Departments of Pharmacology and Psychiatry, University of Toronto, Toronto, Ontario
Can J Psychiatry 47:27-38. 2002..To understand how these drugs work, it is important to examine the atypical antipsychotics' mechanism of action and how it differs from that of the more typical drugs...
- Cannabis and psychosisJohn Macleod
Lancet 370:1539; author reply 1539-40. 2007
- Psychosis associated with prescribed dexamphetamine useJon Spear
Aust N Z J Psychiatry 37:383. 2003
- Mefloquine: contraindicated in patients with mood, psychotic or seizure disordersEric Wooltorton
CMAJ 167:1147. 2002
- The successful use of electroconvulsive therapy in a patient with interferon-induced psychotic depressionMiriam Tanja Zincke
University of Medicine and Dentistry of New Jersey New Jersey Medical School, Newark, NJ 07103, USA
J ECT 23:291-2. 2007..We reviewed the literature of similar cases and discuss treatment options for interferon-induced depression and psychosis...
- [Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease]J R Chacon
Servicios de Neurologia, Hospital Universitario Virgen Macarena, Sevilla, Spain
Neurologia 17:7-11. 2002..To evaluate the antipsychotic efficacy of olanzapine (OLZ) in patients with Parkinson's disease (PD) and drug-induced psychosis (DIP) and its repercussion on the motor function...
- Spiperone binding capacity in lymphocytes of patients with alcohol- and drug-induced psychosis: preliminary resultsM Soyka
Psychiatische Klinik und Poliklinik, , Federal Republic of Germany
J Stud Alcohol 55:503-7. 1994..Possible implications of these findings for future research are discussed...
- A case of disulfiram-methylphenidate interaction: implications for treatmentHerve Caci
Am J Psychiatry 164:1759. 2007
- SERVICE NEEDS IN EARLY PSYCHOSIS AND DRUG USECAROL CATON; Fiscal Year: 2003..Greater knowledge of the long-term course and outcome of these disorders may lead to more appropriate matches to treatment for substance use, and may uncover unmet needs for services. ..
- Cannabinoid Receptor Function in Alcoholism: Effects of D-9-THCDEEPAK D SOUZA; Fiscal Year: 2008..These results may reflect indirect evidence of altered CB-1R function in FHP individuals. [unreadable] [unreadable] [unreadable]..
- Cannabinoids, Neural Synchrony and Information ProcessingDEEPAK D SOUZA; Fiscal Year: 2008..unreadable] [unreadable] [unreadable] [unreadable]..
- HIV Risk Among Homeless MothersCAROL CATON; Fiscal Year: 2007..The study will inform the design of HIV risk behavior preventive interventions appropriate to the life circumstances of homeless mothers. ..
- DRUG USE AND COURSE OF HOMELESSNESS AMONG SINGLE ADULTSCAROL CATON; Fiscal Year: 2003..Greater understanding of factors that determine the course of homelessness has implications for the development of prevention and early intervention strategies. ..
- NEUROBIOLOGY OF CANNABIS EFFECTSDEEPAK D SOUZA; Fiscal Year: 2009....
- GLYCINE-KETAMINE INTERACTIONS IN HEALTHY SUBJECTSDEEPAK D SOUZA; Fiscal Year: 2002..Pilot data (n=12) towards this proposal suggests that glycine reduces ketamine-induced perceptual alterations, negative symptoms and impairments on recall without worsening positive symptoms. ..
- A Peer Support Intervention for Psychosis and Drug UseCAROL CATON; Fiscal Year: 2004..abstract_text> ..
- Chinese Exercise Modalites in Parkinson's DiseaseJorge Juncos; Fiscal Year: 2003..A better understanding of exercise-induced neural plasticity and motor control would offer a significant, and heretofore unexploited rehabilitative potential in PD. ..
- Human Genetics of Drug-Abuse Related PhenotypesJoseph Cubells; Fiscal Year: 2007..The latter goal will be accomplished by the candidate directing the newly-established Yale Human Behavioral Genetics Clinic, which offers psychiatric and substance-abuse services to patients with genetic illnesses. ..
- Flumazenil on Multiple Stress and Withdrawal AnxietyGeorge Breese; Fiscal Year: 2007....
- Serotonin Club IUPHAR Satellite MeetingMark Geyer; Fiscal Year: 2006..Hence, helping neuroscientists-in-training attend the meeting will have a positive influence on trainees and a lasting impact on the field. [unreadable] [unreadable] [unreadable]..
- Symposium on Neuroimaging in AlcoholismJohn Krystal; Fiscal Year: 2007..unreadable] [unreadable] [unreadable]..
- Abnormal Eye Movement in Schizophrenia: Genome-Wide ScanRandal Ross; Fiscal Year: 2008..Linkage in both groups will assessed using methods capable of detecting genetic effects on quantitative traits. ..
- Childhood Physiology and Risk for SchizophreniaRandal Ross; Fiscal Year: 2008..Clarification of this methodology may lead to a novel prenatal intervention strategy designed to decrease risk for adolescent and adult onset of psychosis. ..
- Neural Correlates of Methamphetamine Use in Schizophrenia: An MRS StudyRuth Salo; Fiscal Year: 2007..These findings will have important implications for neurobiological models of comorbid substance abuse and treatment. [unreadable] [unreadable] [unreadable]..
- Prospective Study: Alcoholic & Control Family OffspringMarc A Schuckit; Fiscal Year: 2010..Our ultimate goal is to identify ways to prevent the escalation of drinking and associated problems in young populations. ..
- Stress Sensitization of CRF-Induced Withdrawal BehaviorsGeorge Breese; Fiscal Year: 2009..New treatment strategies could emerge from such knowledge ..
- Genetics of plasma dopamine beta-hydroxylase activity in schizophreniaJoseph Cubells; Fiscal Year: 2009..Identifying predictors of varying outcomes in SCZ would open new avenues for development of targeted interventions that could significantly ameliorate the impact of SCZ on individuals and society. ..
- DEVELOPMENTAL MODELS OF GATING DEFICITS IN SCHIZOPHRENIAMark A Geyer; Fiscal Year: 2010..Hence, Aim 3 studies will test the hypothesized differential roles of specific CRF receptors in mediating isolation rearing-induced deficits in PPI in mice, using CRF-R1 and CRF-R2 null mutant mice. ..
- LEVEL OF RESPONSE TO ALCOHOL AND BRAIN FUNCTIONINGMarc A Schuckit; Fiscal Year: 2010..The project will also expand our understanding of the neural substrates of the level of response to alcohol, a key risk factor for the development of alcohol dependence. ..
- Novel Glutamatergic Detoxification StrategiesJohn Krystal; Fiscal Year: 2006..abstract_text> ..
- Naltrexone for Bipolar Disorder and Alcohol DependenceE Sherwood Brown; Fiscal Year: 2006..Alcohol use is the primary outcome, and alcohol craving is the secondary outcome. Manic and depressive symptom severity and the relationship between changes in alcohol use and changes in mood will be expIored. ..
- MOLECULAR BIOLOGY OF ETHANOL ACTION ON RECEPTORSGeorge Breese; Fiscal Year: 2002..Further, based upon structural analysis of ethanol's action on protein-protein inter-actions for the receptors, results may ultimately allow us to predict other protein-protein interactions influenced by ethanol. ..
- Symposium on Neuroimaging in AlcoholismJohn Krystal; Fiscal Year: 2003..A call for abstracts also will bring forward names and ideas from other groups that might be added to the main program. Young Investigator travel scholarships will be considered. ..
- AMINO ACID NEUROTRANSMITTER DYSREGULATION IN ALCOHOLISMJohn Krystal; Fiscal Year: 2003..In summary, this K02 award would foster my academic development and enable me to better contribute to the building of pathophysiologic models of alcoholism that can guide medications development for this disorder. ..
- EMERGENCY PHYSICIAN BRIEF INTERVENTIONS FOR ALCOHOLGAIL D ONOFRIO; Fiscal Year: 2003..abstract_text> ..
- Treating Asthma Patients with Major Depressive DisorderE Sherwood Brown; Fiscal Year: 2004....
- BEHAVIORAL THERAPY FOR DEPRESSION IN DRUG DEPENDENCEEdward Nunes; Fiscal Year: 2002..3. To test the theory that an increase in response-contingent reinforcement will produce an improvement in depression and reduced drug use. ..
- NEUROSTEROIDS IN THE ACTION OF ETHANOL ON GABAGeorge Breese; Fiscal Year: 2004..Completion of the Aims will allow critical new information to emerge concerning the molecular basis of neurosteroid action on GABAA receptor function that allows ethanol to enhance GABA function in vitro. ..
- HIPPOCAMPAL FUNCTION DURING CORTICOSTEROID THERAPYE Sherwood Brown; Fiscal Year: 2004..Through this award, the Pl will extend his previous research experience by adding new skills and knowledge which will be used for investigations at the interface of neuroscience and clinical research. ..
- White Matter Integrity in Familial SchizophreniaLynn DeLisi; Fiscal Year: 2006..Since this hypothesis has not been tested specifically in this way and is speculative, but if correct, may have a great impact on future research, we are using the R21 exploratory mechanism. ..
- Behavioral Therapy Development for Methamphetamine AbuseJames Peck; Fiscal Year: 2005..Effectiveness data from this research will be used to inform the continued Stage II development of this intervention. ..
- DRUG ABUSE PHARMACOTHERAPY: METHODOLOGIC INITIATIVESEdward Nunes; Fiscal Year: 2005..The applicant will continue to pursue a training plan focused on methodology and statistics of clinical trials, behavioral interventions, and the responsible conduct of research. ..
- Cognitive Sequelae of Methamphetamine AbuseRuth Salo; Fiscal Year: 2005..abstract_text> ..
- NASD Yale New Haven Hospital Emergency Department 2004GAIL D ONOFRIO; Fiscal Year: 2004..abstract_text> ..
- Perinatal Vulnerability to PsychosisRandal Ross; Fiscal Year: 2004....
- NALTREXONE BLOCKADE OF NMDAJohn Krystal; Fiscal Year: 2002..Thus, the blockade of the rewarding effects of ketamine by naltrexone may provide insight into an important mechanism underlying the psychopharmacology of ethanol and the treatment of alcoholism. ..
- AMINO ACID NEUROTRANSMITTER DYSREGULATION IN ALCOHOLISMJohn Krystal; Fiscal Year: 2008..abstract_text> ..
- Enhancing EP-Performed Alcohol Interventions in the EDGAIL D ONOFRIO; Fiscal Year: 2009..abstract_text> ..
- STARTLE GATING AND LOCOMOTION IN D2-FAMILY KNOCKOUT MICEMark Geyer; Fiscal Year: 2004..This information will have important implications for the further development of therapeutic approaches to the treatment of both schizophrenia and drug abuse. ..